ATE450195T1

Analysis of raman spectrum signals from selected regions of the eye

Abstract

A non-invasive method for analyzing the blood-brain barrier includes obtaining a Raman spectrum of a selected portion of the eye and monitoring the Raman spectrum to ascertain a change to the dynamics of the blood brain barrier.Also, non-invasive methods for determining the brain or blood level of an analyte of interest, such as glucose, drugs, alcohol, poisons, and the like, comprises: generating an excitation laser beam (e.g., at a wavelength of 600 to 900 nanometers); focusing the excitation laser beam into the anterior chamber of an eye of the subject so that aqueous humor, vitreous humor, or one or more conjunctiva vessels in the eye is illuminated; detecting (preferably confocally detecting) a Raman spectrum from the illuminated portion of the eye; and then determining the blood level or brain level (intracranial or cerebral spinal fluid level) of an analyte of interest for the subject from the Raman spectrum. In certain embodiments, the detecting step may be followed by the step of subtracting a confounding fluorescence spectrum from the Raman spectrum to produce a difference spectrum; and determining the blood level and/or brain level of the analyte of interest for the subject from that difference spectrum, preferably using linear or nonlinear multivariate analysis such as partial least squares analysis. Apparatus for carrying out the foregoing methods are also disclosed.

Term

Term ended

Projected expiry passed 9 January 2022, 4.7 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

26 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
75689701United States of AmericaA
0200649United States of AmericaW

Members26

Family members, oldest first
DocumentOfficeKind
CA2337097A1CanadaA1
WO0002479A1World Intellectual Property Organization (WIPO)A1
AU4986899AAustraliaA
WO0002479A9World Intellectual Property Organization (WIPO)A9
US6181957B1United States of AmericaB1
EP1093343A1European Patent Office (EPO)A1
US2001034478A1United States of AmericaA1
US6424850B1United States of AmericaB1
CA2438027A1CanadaA1
WO02060321A2World Intellectual Property Organization (WIPO)A2
AU2002248331A1AustraliaA1
US6574501B2United States of AmericaB2
WO02060321A3World Intellectual Property Organization (WIPO)A3
EP1383417A2European Patent Office (EPO)A2
US2004019283A1United States of AmericaA1
US2004127778A1United States of AmericaA1
WO2004086939A2World Intellectual Property Organization (WIPO)A2
WO2004086939A3World Intellectual Property Organization (WIPO)A3
EP1093343A4European Patent Office (EPO)A4
US6961599B2United States of AmericaB2
US7398119B2United States of AmericaB2
CA2337097CCanadaC
EP1383417B1European Patent Office (EPO)B1
AT450195TAustriaT
ATE450195T1This recordAustriaT1
DE60234583D1GermanyD1